Related Experiment Video
Updated: Oct 11, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
SOCS3 Gene Polymorphism and Hypertension Susceptibility in Chinese Population: A Two-Center Case-Control Study
Dabin Kuang1, Lichen Dong1, Lingyun Liu2
1The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, China.
Insights
The Suppressor of Cytokine Signaling 3 (SOCS3) gene variant rs8064821 is linked to a higher risk of hypertension in the Chinese population. This genetic variation may influence hypertension risk by altering SOCS3 gene expression.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- Endothelial inflammation and vascular damage are key risk factors for hypertension.
- Suppressor of Cytokine Signaling 3 (SOCS3) plays a crucial role in regulating inflammatory pathways.
- Previous research highlights SOCS3's anti-inflammatory effects in conditions like hypertension and obesity.
Purpose of the Study:
- To investigate the association between a specific SOCS3 tagSNP (rs8064821) and hypertension risk in the Chinese population.
- To explore the potential role of SOCS3 gene expression in hypertension development.
Main Methods:
- A case-control study involving 532 hypertension patients and 569 healthy controls from central China.
- Genotyping of the SOCS3 rs8064821 C>A polymorphism using the TaqMan assay.
- Analysis of SOCS3 mRNA levels in peripheral blood mononuclear cells (PBMCs) from healthy donors.
Main Results:
- The SOCS3 rs8064821 CA genotype was significantly associated with an increased risk of hypertension (OR = 1.821, P = 0.001).
- The rs8064821 A allele was correlated with higher SOCS3 mRNA expression in PBMCs of healthy individuals.
- These findings suggest a link between the SOCS3 C>A polymorphism and altered SOCS3 expression.
Conclusions:
- The SOCS3 rs8064821 C>A polymorphism may contribute to hypertension susceptibility in the Chinese population.
- The mechanism may involve the regulation of SOCS3 gene expression by this specific polymorphism.
- This study provides genetic insights into the inflammatory pathways involved in hypertension.
Abstract:
Endothelial inflammation and vascular damage are essential risk factors contributing to hypertension. Suppressor of cytokine signaling 3 (SOCS3) is involved in the regulation of multiple inflammatory pathways. A large number of studies have shown that the anti-inflammatory effect of SOCS3 in hypertension, obesity, and allergic reactions has brought more insights into the inhibition of inflammation. Therefore, we selected a tagSNP of SOCS3 (rs8064821) to investigate whether they are contributing to the risk of hypertension in the Chinese population. In total, 532 patients with hypertension and 569 healthy controls were enrolled for two central of China. SOCS3 rs8064821 C>A polymorphism was genotyped using TaqMan assay. SOCS3 rs8064821 CA genotype was associated with an increased risk of hypertension (OR = 1.821, 95%CI = 1.276-2.600, P = 0.001). Rs8064821 A allele was associated with higher SOCS3 mRNA level in PBMCs from healthy donors. SOCS3 rs8064821 C>A polymorphism may contribute to the risk of hypertension in the Chinese population by regulating the expression of SOCS3.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Single Nucleotide Polymorphisms-SNPs
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

